Non classé

At EuroMIT 2026, the international congress dedicated to mitochondrial diseases currently being held in Angers,… Read More »EuroMIT 2026: two sessions reserved for patients

The national diagnosis and care protocol (PNDS) for mitochondrial diseases linked to POLG mutations (DNA polymerase gamma)… Read More »PNDS for mitochondrial diseases linked to POLG mutations

EuroMIT 2026, the next international congress dedicated to mitochondrial diseases, will take place in Angers… Read More »EuroMIT 2026 is in the starting blocks!

It’s not always easy to find medical and scientific publications on mitochondrial diseases. At AFM-Téléthon,… Read More »The new AFM-Téléthon quarterly watch is out!

The main obstacle to treating Leigh syndrome is the blood–brain barrier, the brain’s ultra-selective protective… Read More »Focused Ultrasound: the brain finally accessible to gene therapy for Leigh Syndrome

The Ouvrir les yeux (OLY) association awards two prizes to young PhD graduates in science,… Read More »Young PhD: submit your application for the 2026 Ouvrir les yeux Hope Prizes without delay!

AFM-Téléthon has just published a Repères Savoir & Comprendre dedicated to mitochondrial diseases. The aim of this guide is… Read More »Publication of the Repères “Mitochondrial Diseases”

Kygevvi®, the treatment developed by UCB for thymidine kinase 2 deficiency (TK2d), has just received… Read More »TK2 Deficiency: Kygevvi® on the verge of approval in Europe

It’s not always easy to find medical and scientific publications on mitochondrial diseases. At AFM-Téléthon,… Read More »The new AFM-Téléthon quarterly watch is out!